Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z
EMBO J. 1986 Nov;5(11):2805-8. doi: 10.1002/j.1460-2075.1986.tb04571.x.
The existence of a third tachykinin receptor (SP-N) in the mammalian nervous system was demonstrated by development of highly selective agonists. Systematic N-methylation of individual peptide bonds in the C-terminal hexapeptide of substance P gave rise to agonists which specifically act on different receptor subtypes. The most selective analog of this series, succinyl-[Asp6,Me-Phe8]SP6-11, elicits half-maximal contraction of the guinea pig ileum through the neuronal SP-N receptor at a concentration of 0.5 nM. At least 60,000-fold higher concentrations of this peptide are required to stimulate the other two tachykinin receptors (SP-P and SP-E). The action of selective SP-N agonists in the guinea pig ileum is antagonized by opioid peptides, suggesting a functional counteraction between opiate and SP-N receptors. These results indicate that the tachykinin receptors are distinct entities which may mediate different physiological functions.
高选择性激动剂的研发证实了哺乳动物神经系统中存在第三种速激肽受体(SP-N)。对P物质C端六肽中各个肽键进行系统性N-甲基化,产生了能特异性作用于不同受体亚型的激动剂。该系列中最具选择性的类似物琥珀酰-[天冬氨酸6,甲基-苯丙氨酸8]P物质6-11,在浓度为0.5 nM时通过神经元SP-N受体引起豚鼠回肠半数最大收缩。刺激另外两种速激肽受体(SP-P和SP-E)需要至少高60000倍的该肽浓度。豚鼠回肠中选择性SP-N激动剂的作用被阿片肽拮抗,提示阿片受体与SP-N受体之间存在功能性拮抗作用。这些结果表明,速激肽受体是不同的实体,可能介导不同的生理功能。